This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Bio-Techne Corp. slid 3.0% to $51.54 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.8% to 6,229.98 and Dow Jones Industrial Average falling 0.9% to 44,406.36.
This was the stock's second consecutive day of losses.
Bio-Techne Corp. closed 38.4% below its 52-week high of $83.62, which the company reached on July 31st.
The stock underperformed when compared to some of its competitors, as Amgen Inc. fell 1.8% to $292.95, Charles River Laboratories International Inc. fell 2.0% to $153.90, and BioMarin Pharmaceutical Inc. fell 0.16% to $57.41.
Trading volume totaled 2.1 million, compared to the 50-day average of 2.4 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 07, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.